Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC v. Garvey

This article was originally published in The Tan Sheet

Executive Summary

Commission files notice of appeal Jan. 23 following Los Angeles federal court's ruling that former baseball player Steve Garvey's statements about Enforma Natural Products' weight-loss supplements were not "knowingly false" or made with "reckless disregard of the truth" (1"The Tan Sheet" Nov. 11, 2002, p. 7). Appeal follows Commissioner Thomas Leary's remarks at Jan. 16 conference that FTC plans to seek consumer redress for false ad claims from endorsers...

You may also be interested in...



Enforma Spokesman Garvey Not Liable For Weight-Loss Claims – Judge

The Federal Trade Commission presented insufficient evidence to support its claim that a former baseball player's statements about the efficacy of Enforma Natural Products' weight-loss supplements were "knowingly false" or made with "reckless disregard of the truth," a federal judge has concluded

Vaccine Company CEOs Face Supply Probe In EU

AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.

Trial Shows Lateral Flow Antibody Testing Could Be Used To Assess COVID-19 Vaccine Efficacy

Abingdon Health has announced that a study run in conjunction with the UK Rapid Test Consortium has demonstrated that its AbC-19 test could be an effective tool for testing vaccine efficacy. 

Topics

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel